Vaxart Intensifies Proxy Battle, Urges Shareholders to Vote for Current Board
VXRT has more than doubled off its 52-week low of $0.261.
Summary
Vaxart has filed additional proxy materials, including social media communications, to solicit shareholder votes for its current director nominees amidst an active proxy contest.
Key Events · Corporate Governance and Compliance · VXRT
-
Active Proxy Contest
Vaxart is engaged in an ongoing proxy contest with a shareholder group seeking to elect new directors to the board.
-
Company Defends Current Board
Vaxart is actively campaigning via social media, emphasizing its board's proven expertise and criticizing the dissident nominees' lack of relevant experience.
-
Shareholder Vote Solicitation
The company is urging shareholders to vote the WHITE proxy card "FOR" its six current director nominees and "WITHHOLD" on the shareholder nominees.
-
Follows Recent Financial Turnaround
This proxy battle occurs shortly after Vaxart reported a significant financial turnaround in Q1 2026, achieving profitability and alleviating its going concern warning.
Analysis · VXRT · Life Sciences
Vaxart is actively campaigning against dissident shareholders in an ongoing proxy contest, using social media to highlight its board's expertise and criticize the opposition. The outcome of this vote is critical for the company's strategic direction, especially following its recent financial turnaround and alleviation of a going concern warning.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 36.1% of the 1051 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.56%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, VXRT was trading at $0.54 on OTC in the Life Sciences sector, with a market capitalization of approximately $130.6M. The 52-week trading range was $0.26 to $0.84. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.